Recognizing Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: A Case Report.

Synjardy (empagliflozin/metformin) - Boehringer Ingelheim, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42732326

Astrid J Batista; Jose C Serrano Reyes; Maria F Carrillo; Rolando L Jaen

Sep 14, 2026